Douwe F. Samplonius

Simultaneous Inhibition of Epidermal Growth Factor Receptor (EGFR) Signaling and Enhanced Activation of Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Receptor-mediated Apoptosis Induction by an scFv:sTRAIL Fusion Protein with Specificity for Human EGFR

Edwin Bremer, Douwe F. Samplonius, Linda van Genne et al. · Journal of Biological Chemistry · 2005 · 97 citations · Full text

Signal Transduction, Simultaneous Inhibition, Therapeutic Apoptosis Induction +15

Target Cell–Restricted Apoptosis Induction of Acute Leukemic T Cells by a Recombinant Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Fusion Protein with Specificity for Human CD7

Edwin Bremer, Douwe F. Samplonius, Matthias Peipp et al. · Cancer Research · 2005 · 88 citations · Full text

Target cell‐restricted and ‐enhanced apoptosis induction by a scFv:sTRAIL fusion protein with specificity for the pancarcinoma‐associated antigen EGP2

Edwin Bremer, Jos M.A. Kuijlen, Douwe F. Samplonius et al. · International Journal of Cancer · 2003 · 87 citations · Full text

CD103+ intraepithelial T cells in high-grade serous ovarian cancer are phenotypically diverse TCRαβ+ CD8αβ+ T cells that can be targeted for cancer immunotherapy

Fenne L. Komdeur, Maartje C.A. Wouters, Hagma H. Workel et al. · Oncotarget · 2016 · 68 citations · Full text

Checkpoint Inhibition, Lymphocyte Development, T-regulatory Cell +23

CD20-selective inhibition of CD47-SIRPα “don't eat me” signaling with a bispecific antibody-derivative enhances the anticancer activity of daratumumab, alemtuzumab and obinutuzumab

Peter E. van Bommel, Yuan He, Ilona Schepel et al. · OncoImmunology · 2017 · 65 citations · Full text